封面
市场调查报告书
商品编码
1473793

介入性脊椎市场 - 按产品、应用、手术类型、最终用途 - 全球预测,2024 年 - 2032 年

Interventional Spine Market - By Product, Application, Surgery Type, End-use - Global Forecast, 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 320 Pages | 商品交期: 2-3个工作天内

价格
简介目录

由于微创技术的不断进步以及对脊椎疾病有效疼痛管理解决方案的关注,2024 年至 2032 年全球介入性脊椎市场规模将录得 4.8% 的复合年增长率。由于微创手术可以缩短恢復时间并减少术后疼痛,患者和医疗保健提供者越来越多地选择这些方法。此外,机器人辅助手术等技术升级提高了脊椎手术的精确度和安全性。随着对侵入性较小但有效的治疗的需求的增加,介入脊椎产业将扩大以满足这些不断变化的需求。

例如,2022年11月,SeaSpine推出了7D FLASH导航系统的经皮脊椎模组,透过脊椎手术的精确引导来增强微创手术能力。

介入脊椎市场根据产品、手术类型、最终用途、应用和地区而分散。

到 2032 年,由于椎体压迫性骨折盛行率上升,特别是在老年人口中,椎体压迫性骨折治疗领域将显着激增。椎体成形术和椎体后凸成形术等治疗方法为缓解疼痛和稳定骨折提供了微创且有效的解决方案。随着人们越来越关注改善脊椎疾病患者的生活质量,椎体压迫性骨折治疗领域将继续在介入性脊椎产业保持成长轨迹。

到 2032 年,在这些诊所在诊断和治疗脊椎相关疾病方面提供的专业护理和专业知识的推动下,专科诊所部门将累积显着的介入性脊椎市场份额。专科诊所仅专注于脊椎治疗,提供全面的护理,包括微创手术和復健服务。寻求脊椎疾病专门护理的患者越来越多地转向这些诊所,推动了市场的成长。凭藉专门的脊椎健康方法和一系列治疗选择,专科诊所部门将保持其在介入脊椎市场的主导地位。

由于该地区完善的医疗基础设施、对研发的高度重视以及先进医疗技术的高采用率,2024年至2032年欧洲介入脊椎产业将呈现出引人注目的复合年增长率。德国和英国等国家处于脊椎手术和创新治疗的前沿。此外,老年人口中脊椎相关疾病的日益流行也促进了市场的成长。欧洲将重点关注以患者为中心的护理和获得尖端治疗,将成为介入脊椎行业的关键贡献者,推动脊椎医疗保健的进步。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 脊椎疾病盛行率上升
      • 微创手术的需求不断增加
      • 技术进步
      • 用于开发更先进技术的公共和私人投资增加
    • 产业陷阱与挑战
      • 脊椎手术费用高
      • 严格的监管场景
  • 成长潜力分析
  • 监管环境
  • 技术景观
  • 波特的分析
  • PESTEL分析
  • 未来市场趋势

第 4 章:竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章:市场估计与预测:按产品分类,2018 年 - 2032 年

  • 主要趋势
  • 胸椎融合器和腰椎融合器
    • 后胸椎融合器和腰椎融合器
    • 胸椎椎间融合器和腰椎椎间融合器
    • 前路胸椎融合器与腰椎融合器
  • 颈椎融合器
    • 颈椎前路融合器
    • 颈椎后路融合器
  • 椎体压迫性骨折治疗装置
    • 球囊椎体后凸成形术装置
    • 椎体成形术设备
  • 脊椎生物製剂
    • 去矿骨基质
    • 骨形态发生蛋白
    • 骨替代品
    • 机械加工骨头
    • 基于细胞的矩阵
    • 同种异体骨
  • 脊椎减压装置
    • 椎间盘切除术
    • 椎板成形术、椎板切除术和椎板切开术
    • 椎间孔切开术和椎间孔切除术
    • 小关节面切除术
    • 椎体切除术
  • 非融合装置
    • 动态稳定
    • 人工椎间盘置换
      • 人工颈椎间盘
      • 人工腰椎间盘
    • 环空修復装置
    • 核椎间盘假体
  • 脊椎骨刺激器
    • 非侵入性脊椎骨刺激器
      • 脉衝电磁场装置
      • 电容耦合 (CC) 装置
      • 组合(电)磁场 (CMF) 设备
    • 侵入式脊椎骨刺激器

第 6 章:市场估计与预测:按应用划分,2018 年 - 2032 年

  • 主要趋势
  • 脊椎融合与固定
  • 椎体压迫性骨折治疗
  • 运动保留/非融合
  • 脊椎减压

第 7 章:市场估计与预测:按手术类型,2018 年 - 2032 年

  • 主要趋势
  • 开放性手术
  • 微创手术

第 8 章:市场估计与预测:按最终用途,2018 - 2032 年

  • 主要趋势
  • 医院
  • 专科诊所
  • 门诊手术中心
  • 其他最终用户

第 9 章:市场估计与预测:按地区划分,2018 年 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第 10 章:公司简介

  • Alphatec Holdings, Inc.
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • ChoiceSpine LLC
  • DePuy Synthes
  • Globus Medical, Inc.
  • Integra LifeSciences Corporation
  • Medtronic plc
  • Nuvasive, Inc.
  • Orthofix Medical Inc.
  • RTI Surgical
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
简介目录
Product Code: 8198

Global Interventional Spine Market Size will record a 4.8% CAGR between 2024 and 2032 due to continuous advancements in minimally invasive techniques and a focus on effective pain management solutions for spine conditions. With minimally invasive procedures offering reduced recovery times and less postoperative pain, patients and healthcare providers are increasingly opting for these approaches. Additionally, technological upgrades like robotic-assisted surgeries improve the precision and safety of spine procedures. As the demand for less invasive yet effective treatments rises, the interventional spine industry will expand to meet these evolving needs.

For instance, in November 2022, SeaSpine introduced the 7D FLASH navigation system's percutaneous spine module, enhancing minimally invasive surgical capabilities with precise guidance for spinal procedures.

The interventional spine market is fragmented based on product, surgery type, end-use, application, and region.

The vertebral compression fracture treatment segment will see a notable surge by 2032, attributed to the rising prevalence of vertebral compression fractures, particularly in aging populations. Treatments such as vertebroplasty and kyphoplasty offer minimally invasive and effective solutions for pain relief and fracture stabilization. With a growing focus on improving the quality of life for patients with spinal conditions, the vertebral compression fracture treatment segment will continue its growth trajectory in the interventional spine industry.

The specialty clinics segment will amass a remarkable interventional spine market share by 2032, driven by the specialized care and expertise offered by these clinics in diagnosing and treating spine-related disorders. Specialty clinics focus solely on spine treatments, providing comprehensive care that includes minimally invasive procedures and rehabilitation services. Patients seeking specialized care for spinal conditions are increasingly turning to these clinics, driving the market growth. With a dedicated approach to spine health and a range of treatment options, the specialty clinics segment will maintain its dominance in the interventional spine market.

Europe interventional spine industry will exhibit a noteworthy CAGR from 2024 to 2032, owing to the region's well-established healthcare infrastructure, strong emphasis on research and development, and high adoption rates of advanced medical technologies. Countries like Germany and the UK are at the forefront of spine surgeries and innovative treatments. Additionally, the growing prevalence of spine-related disorders in the aging population contributes to market growth. With a focus on patient-centric care and access to cutting-edge treatments, Europe will stand as a pivotal contributor to the interventional spine industry, shaping advancements in spinal healthcare.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of spinal diseases
      • 3.2.1.2 Increasing demand for minimally invasive procedures
      • 3.2.1.3 Technological advancements
      • 3.2.1.4 Rise in public and private investments for the development of more advanced technologies
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of spinal surgeries
      • 3.2.2.2 Stringent regulatory scenario
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Porter's analysis
    • 3.6.1 Supplier power
    • 3.6.2 Buyer power
    • 3.6.3 Threat of new entrants
    • 3.6.4 Threat of substitutes
    • 3.6.5 Industry rivalry
  • 3.7 PESTEL analysis
  • 3.8 Future market trends

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Thoracic fusion and lumbar fusion devices
    • 5.2.1 Posterior thoracic fusion and lumbar fusion devices
    • 5.2.2 Interbody thoracic fusion and lumbar fusion devices
    • 5.2.3 Anterior thoracic fusion and lumbar fusion devices
  • 5.3 Cervical fusion devices
    • 5.3.1 Anterior cervical fusion devices
    • 5.3.2 Posterior cervical fusion devices
  • 5.4 Vertebral compression fracture treatment devices
    • 5.4.1 Balloon kyphoplasty devices
    • 5.4.2 Vertebroplasty devices
  • 5.5 Spine biologics
    • 5.5.1 Demineralized bone matrix
    • 5.5.2 Bone morphogenetic proteins
    • 5.5.3 Bone substitutes
    • 5.5.4 Machined bones
    • 5.5.5 Cell-based matrices
    • 5.5.6 Allograft bone
  • 5.6 Spinal decompression devices
    • 5.6.1 Discectomy
    • 5.6.2 Laminoplasty, laminectomy, and laminotomy
    • 5.6.3 Foraminotomy & foraminectomy
    • 5.6.4 Facetectomy
    • 5.6.5 Corpectomy
  • 5.7 Non-fusion devices
    • 5.7.1 Dynamic stabilization
    • 5.7.2 Artificial discs replacement
      • 5.7.2.1 Artificial cervical disc
      • 5.7.2.2 Artificial lumbar disc
    • 5.7.3 Annulus repair devices
    • 5.7.4 Nuclear disc prostheses
  • 5.8 Spine bone stimulators
    • 5.8.1 Noninvasive spine bone stimulators
      • 5.8.1.1 Pulsed electromagnetic field devices
      • 5.8.1.2 Capacitive coupling (CC) devices
      • 5.8.1.3 Combined (electro) magnetic field (CMF) devices
    • 5.8.2 Invasive spine bone stimulators

Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Spinal fusion and fixation
  • 6.3 Vertebral compression fracture treatment
  • 6.4 Motion preservation/non-fusion
  • 6.5 Spinal decompression

Chapter 7 Market Estimates and Forecast, By Surgical Type, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Open surgeries
  • 7.3 Minimally invasive surgeries

Chapter 8 Market Estimates and Forecast, By End-use, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Specialty clinics
  • 8.4 Ambulatory surgical centers
  • 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Alphatec Holdings, Inc.
  • 10.2 B. Braun Melsungen AG
  • 10.3 Boston Scientific Corporation
  • 10.4 ChoiceSpine LLC
  • 10.5 DePuy Synthes
  • 10.6 Globus Medical, Inc.
  • 10.7 Integra LifeSciences Corporation
  • 10.8 Medtronic plc
  • 10.9 Nuvasive, Inc.
  • 10.10 Orthofix Medical Inc.
  • 10.11 RTI Surgical
  • 10.12 Stryker Corporation
  • 10.13 Zimmer Biomet Holdings, Inc.